BeStock  
Stocks › Biotechnology › ANRO

Alto Neuroscience ANRO

US equityMarket cap rank #3294Biotechnology
$23.52 −$0.17 (-0.72%)
Pre-market · Oct 8, 8:20 am ET · After hours $23.97 +1.92%
Open$23.39
Prev close$23.69
Day range$23.33 – $24.42
Volume348.0K
Market cap$922.97M
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-10.1x
CheapRich

Below its usual level · 20th percentile, 5-year average -6.0x

Price / book4.2x
CheapRich

Above its usual level · 79th percentile, 5-year average 1.5x

#4100 of 5317 stocks by PB (1 = cheapest)

P/E over five years

-17x-11x-5x1xJan '24May '25Oct '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$19.54
Price vs. fair value+20.4%Trading above the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyExtreme
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 4.21 – 1.46 79% (pricier than usual) #4100 of 5317 (1 = cheapest)
PE -10.14 -7.42 -5.98 20% (cheaper than usual) –
PS – – 0.00 – –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★
Fair value estimate$19.54
Economic moatNone
UncertaintyExtreme

Discussion

No comments yet — be the first to weigh in on ANRO.

Leave a comment

Scroll to Top